These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17880451)

  • 21. Musculoskeletal problems in persons with inhibitors: how do we treat?
    Caviglia H; Narayan P; Forsyth A; Giangrande P; Gilbert M; Goddard N; Mulder K; Rahim S
    Haemophilia; 2012 Jul; 18 Suppl 4():54-60. PubMed ID: 22726084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophilia in Spain.
    Aznar JA; Lucía F; Abad-Franch L; Jiménez-Yuste V; Pérez R; Batlle J; Balda I; Parra R; Cortina VR
    Haemophilia; 2009 May; 15(3):665-75. PubMed ID: 19432921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disability in Indian patients with haemophilia.
    Kar A; Mirkazemi R; Singh P; Potnis-Lele M; Lohade S; Lalwani A; Saha AS
    Haemophilia; 2007 Jul; 13(4):398-404. PubMed ID: 17610556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The orthopaedic status of severe haemophiliacs in Spain.
    Aznar JA; Magallón M; Querol F; Gorina E; Tusell JM
    Haemophilia; 2000 May; 6(3):170-6. PubMed ID: 10792475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV and HCV coinfected haemophilia patients: what are the best options of orthopaedic treatment?
    Rodriguez-Merchan EC
    Haemophilia; 2006 Jul; 12 Suppl 3():90-101. PubMed ID: 16684002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent factor VIII inhibitors and orthopaedic complications in children with severe haemophilia A.
    Abdel-Messih IY; Habashy DM; Moftah SG; ElAlfy MS
    Haemophilia; 2011 May; 17(3):490-3. PubMed ID: 21371185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison between prophylaxis and on demand treatment for severe haemophilia.
    Khoriaty R; Taher A; Inati A; Lee C
    Clin Lab Haematol; 2005 Oct; 27(5):320-3. PubMed ID: 16178913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.
    Franchini M; Girelli D; Olivieri O; Castaman G; Lippi G; Poli G; Salvagno GL; Tagariello G; Giuffrida A; de Gironcoli M; Morfini M; Berntorp E; Gandini G
    Haemophilia; 2006 Jul; 12(4):448-51. PubMed ID: 16834751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased burden on caregivers of having a child with haemophilia complicated by inhibitors.
    Lindvall K; von Mackensen S; Elmståhl S; Khair K; Stain AM; Ljung R; Berntorp E
    Pediatr Blood Cancer; 2014 Apr; 61(4):706-11. PubMed ID: 24277475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors.
    Leissinger CA; Becton DL; Ewing NP; Valentino LA
    Haemophilia; 2007 May; 13(3):249-55. PubMed ID: 17498073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density.
    Khawaji M; Akesson K; Berntorp E
    Haemophilia; 2009 Jan; 15(1):261-6. PubMed ID: 19149852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
    Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
    Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis therapy in haemophilia A: current situation in Spain.
    Lucía JF; Aznar JA; Abad-Franch L; Escuin RR; Jiménez-Yuste V; Pérez R; Batlle J; Balda I; Alperovich G; Parra R;
    Haemophilia; 2011 Jan; 17(1):75-80. PubMed ID: 21070481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orthopaedic surgery in haemophilia patients with inhibitors as the last resort.
    Rodriguez-Merchan EC; Quintana M; Jimenez-Yuste V
    Haemophilia; 2008 Nov; 14 Suppl 6():56-67. PubMed ID: 19134035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arthropathy in inhibitor patients: differences in the joint status.
    Hoots WK
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S42-9. PubMed ID: 18544425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilia care in children--benefits of early prophylaxis for inhibitor prevention.
    Mancuso ME; Graca L; Auerswald G; Santagostino E
    Haemophilia; 2009 Jan; 15 Suppl 1():8-14. PubMed ID: 19125935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population.
    du Treil S; Rice J; Leissinger CA
    Haemophilia; 2007 Sep; 13(5):493-501. PubMed ID: 17880435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Joint health scores in a haemophilia A cohort from Pakistan with minimal or no access to factor VIII concentrate: correlation with thrombin generation and underlying mutation.
    Khanum F; Bowen DJ; Kerr BC; Collins PW
    Haemophilia; 2014 May; 20(3):426-34. PubMed ID: 24354535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors].
    Honda K; Nagao T; Kamiya T; Yoshioka A; Miyazaki T; Takeda T; Mori K; Fukutake K; Hanabusa H; Taki M; Mohri H; Miyama J; Takamatsu J; Kinoshita S; Shirahata A
    Rinsho Ketsueki; 1998 Jun; 39(6):416-21. PubMed ID: 9695668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.